The impact of changing pathogens of serious infections in hospitalized patients

被引:14
作者
McGowan, JE
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med Infect Dis, Atlanta, GA USA
关键词
D O I
10.1086/314077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New epidemiological patterns are being observed for multidrug-resistant nosocomial organisms. Current problems include the appearance of resistance determinants in organisms that are virulent enough to cause infection in patients with normal host defenses. In addition, multidrug-resistant organisms are spreading from health care to community settings, and organisms from the community are spreading to health care settings. The appearance and spread of resistance can be examined both at a molecular level and on a larger scale involving several pathways. Potential pathways within institutions include the following: introduction of new strains from outside sources (e.g,, patients or health care workers from other institutions); exchange of resistance determinants via genetic mutation or transfer of genetic material; emergence or selection of resistant strains following exposure to antimicrobials; and clonal dissemination. Strategies such as multidisciplinary management of infections, appropriate infection control measures, and surveillance of resistance patterns are necessary to address the problem of resistance.
引用
收藏
页码:S124 / S130
页数:7
相关论文
共 75 条
[1]   Consequences of increasing resistance to antimicrobial agents [J].
Acar, JF ;
Goldstein, FW .
CLINICAL INFECTIOUS DISEASES, 1998, 27 :S125-S130
[2]  
Adeyemi-Doro AB, 1997, INFECT CONT HOSP EP, V18, P765
[3]  
Akram J, 1998, INFECT CONT HOSP EP, V19, P106
[4]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[5]   Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain:: Results of a 1-year (1996-1997) multicenter surveillance study [J].
Baquero, F ;
García-Rodríguez, JA ;
de Lomas, JG ;
Aguilar, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :357-359
[6]  
BOYCE JM, 1997, STAPHYLOCOCCI HUMAN, P309, DOI DOI 10.1002/9781444308464.CH15
[7]   Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032 [J].
Bozdogan, B ;
Leclercq, R ;
Lozniewski, A ;
Weber, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :2097-2098
[8]   Novelties in the field of anti-infectives in 1998 [J].
Bryskier, A .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :632-658
[9]   Metallo-β-lactamases:: A class apart [J].
Bush, K .
CLINICAL INFECTIOUS DISEASES, 1998, 27 :S48-S53
[10]  
*CDCP, 2000, JAMA-J AM MED ASSOC, V283, P599